126 related articles for article (PubMed ID: 20590025)
1. [Diabetic patient with liver or kidney disease. Which antidiabetics are allowed?].
Stiefelhagen P
MMW Fortschr Med; 2010 Jun; 152(22):18. PubMed ID: 20590025
[No Abstract] [Full Text] [Related]
2. [Antidiabetic agents and renal insufficiency].
Robles NR; Blanco J
Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
[No Abstract] [Full Text] [Related]
3. Insulin detemir (levemir), a new long-acting insulin.
Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
[TBL] [Abstract][Full Text] [Related]
4. Insuline glusine (Apidra): a new rapid-acting insulin.
Med Lett Drugs Ther; 2006 Apr; 48(1233):33-4. PubMed ID: 16625142
[TBL] [Abstract][Full Text] [Related]
5. Insulin therapy components.
Moses A
Am Fam Physician; 2004 Dec; 70(11):2081. PubMed ID: 15606055
[No Abstract] [Full Text] [Related]
6. Insulin glulisine. Aventis Pharma.
Barlocco D
Curr Opin Investig Drugs; 2003 Oct; 4(10):1240-4. PubMed ID: 14649217
[TBL] [Abstract][Full Text] [Related]
7. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
[No Abstract] [Full Text] [Related]
8. [Insulin requirement in patients with type 1 diabetes with reduced renal function: human insulin versus analogue insulin].
Hasslacher C; Vogt C; Raupp D; Dreyhaupt J
Dtsch Med Wochenschr; 2007 Nov; 132(47):2500-4. PubMed ID: 18027324
[TBL] [Abstract][Full Text] [Related]
9. Oral hypoglycemics and diabetic nephropathy.
Hadler NM
Clin J Am Soc Nephrol; 2008 Jan; 3(1):159-62. PubMed ID: 18178782
[No Abstract] [Full Text] [Related]
10. [Early insulin administration in obese patients with type 2 diabetes makes sense--contra].
Schusdziarra V
Dtsch Med Wochenschr; 2008 Apr; 133(17):920. PubMed ID: 18415918
[No Abstract] [Full Text] [Related]
11. [Early insulin administration in obese patients with type 2 diabetes makes sense--pro].
Dreyer M
Dtsch Med Wochenschr; 2008 Apr; 133(17):919. PubMed ID: 18415917
[No Abstract] [Full Text] [Related]
12. Biphasic insulin aspart in the treatment of type 2 diabetes mellitus.
Cucinotta D; Russo GT
Expert Opin Pharmacother; 2009 Dec; 10(17):2905-11. PubMed ID: 19929709
[TBL] [Abstract][Full Text] [Related]
13. Insulin aspart: a review.
Owens D; Vora J
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
[TBL] [Abstract][Full Text] [Related]
14. Insulin therapy in renal disease.
Iglesias P; Díez JJ
Diabetes Obes Metab; 2008 Sep; 10(10):811-23. PubMed ID: 18248491
[TBL] [Abstract][Full Text] [Related]
15. [The new insulins].
Krzentowski G
Rev Med Brux; 2005 Sep; 26(4):S241-5. PubMed ID: 16240869
[TBL] [Abstract][Full Text] [Related]
16. [Novo Nordisk introduces a new basic insulin for marketing].
Krankenpfl J; 2004; 42(5-6):168-9. PubMed ID: 15527230
[No Abstract] [Full Text] [Related]
17. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
Snyder RW; Berns JS
Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
[TBL] [Abstract][Full Text] [Related]
18. Improving post-prandial control with Humalog and Humalog mixtures.
Lüddeke HJ
Int J Clin Pract Suppl; 2000 Sep; (112):23-8. PubMed ID: 11064948
[No Abstract] [Full Text] [Related]
19. Diabetes mellitus--overview.
Hoogwerf BJ; Sferra J; Donley BG
Foot Ankle Clin; 2006 Dec; 11(4):703-15. PubMed ID: 17097511
[TBL] [Abstract][Full Text] [Related]
20. Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus.
Ersoy A; Ersoy C; Altinay T
Nephrol Dial Transplant; 2006 Feb; 21(2):553-4. PubMed ID: 16221693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
